Metraipolis › archive › dc_77062263bb87

Efficacy and safety of transarterial chemoembolization combined with sintilimab and bevacizumab in hepatocellular carcinoma — Europe PMC PMID:41602381

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41602381
DOI
10.3389/fonc.2025.1739249
License (as archived)
solo-consultazione
Archived
2026-11-06T21:49:03.744Z
SHA-256 of the archived text
4d2fab410b8f5a47a70b396de6b77003a3bf5b1aa1c40650b271e19d57d6175a
Stable URL of this page
https://metraipolis.com/documento/dc_77062263bb87

How to cite

Efficacy and safety of transarterial chemoembolization combined with sintilimab and bevacizumab in hepatocellular carcinoma — Europe PMC PMID:41602381 — Europe PMC (en), https://europepmc.org/article/MED/41602381 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_77062263bb87 (Metraipolis archive dc_77062263bb87, sha256 4d2fab410b8f5a47a70b396de6b77003a3bf5b1aa1c40650b271e19d57d6175a)
BibTeX
@misc{dc77062263bb87,
  title = {Efficacy and safety of transarterial chemoembolization combined with sintilimab and bevacizumab in hepatocellular carcinoma — Europe PMC PMID:41602381},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41602381},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_77062263bb87; sha256 4d2fab410b8f5a47a70b396de6b77003a3bf5b1aa1c40650b271e19d57d6175a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41602381. Agents can read the archived copy with the MCP tool read_document.